FDA Roundup: February 23, 2024
February 24, 2024
February 24, 2024
WASHINGTON, Feb. 24 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following roundup on Feb. 23, 2024:
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
* Today, the FDA announced its final decision to withdraw approval of Pepaxto (melphalan flufenamide), which was approved for use in combination with dexamethasone to treat certain patients with multiple mye . . .
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
* Today, the FDA announced its final decision to withdraw approval of Pepaxto (melphalan flufenamide), which was approved for use in combination with dexamethasone to treat certain patients with multiple mye . . .